Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. (Q51714520)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2015

Language	Label	Description	Also known as
English	Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.	scientific article published on 16 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. (English)

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

1 reference

based on heuristic

inferred from title

Véronique Miette

object named as

Véronique Miette

12

0 references

author name string

Magali Sasso

1

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Stéphane Audière

2

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Astrid Kemgang

3

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Farid Gaouar

4

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Christophe Corpechot

5

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Olivier Chazouillères

6

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Céline Fournier

7

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Olivier Golsztejn

8

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Stéphane Prince

9

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Yves Menu

10

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

Laurent Sandrin

11

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

publication date

16 September 2015

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

42

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

1

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

92-103

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Transient elastography (FibroScan)

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Ultrasonic absorption and attenuation in mammalian tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Clinical application of an ultrasound attenuation coefficient estimation technique for liver pathology characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Ultrasound focal lesion detectability phantoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Attenuation of ultrasound in normal liver and diffuse liver disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Liver stiffness: a novel parameter for the diagnosis of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

The effect of trabecular material properties on the frequency dependence of backscatter from cancellous bone

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2015.08.008

7 January 2021

Identifiers

10.1016/J.ULTRASMEDBIO.2015.08.008

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

release_gfszxjukprbrrb6amm4rzk662i

1 reference

https://api.fatcat.wiki/v0/release/gfszxjukprbrrb6amm4rzk662i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/26386476

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51714520&oldid=2076069932"